Proarrhythmic potential of metoclopramide in a sensitive whole-heart model.
Julian WolfesChristian EllermannSophie BurdeMichael FehrLars EckardtGerrit FrommeyerPublished in: Basic & clinical pharmacology & toxicology (2021)
This is the first experimental study that investigated the effect of increasing doses of metoclopramide on a sensitive whole-heart model of proarrhythmia. MCP led to a significant increase in action potential duration and QT interval; meanwhile, the number of ventricular tachycardias was significantly increased.